DNV  Capital

Developing New Value

DNV  Capital

Developing New Value

Introduction

DNV Capital, founded by a group of experienced industrial professionals and capital market elites, is an international venture capital firm focusing on the investments in healthcare and innovative technology industry.

DNV Capital concentrates on venture capital investment in start-up period and growth period, the directions of investment cover: medical treatment and health industry (including technology-leading pharmaceutic preparations, biological products, medical equipment and medical facilities; market-leading medical care providers, tele-medicine and health management) and innovative technology industry (including artificial intelligence (AI), Internet of Things, high-end robot, 3D printing, sensor and cloud computing).

DNV Capital is honored to be the member of Shenzhen Private Equity Association and Zhongguancun Private Equity& Venture Capital Association.

Team

Managing Partner

Kevin Lin

Partner

Steven Bai

Partner

Frank Wang

Partner

Zhe Yang

Portfolio

News

FiRe Convenes Selects TruTag as a 2017 Firestarter Company

Strategic News ServiceTM (SNS) has selected TruTag Technologies as a 2017 FiReStarter company to be featured at the 15th annual Future in Review (FiRe) Conference. FiRe 2017 will take place October 10-13 at the Stein Eriksen Lodge Deer Valley in Park City, Utah.

Kevin Lin was Awarded the Best Cross-border Investor on ChinaVenture-Hurun Midas List 2016

 Kevin Lin, founding manager of DNVCapital, was awarded the Best Cross-border Investor on ChinaVenture-Hurun Midas List 2016.

Kevin Lin Won the Best Global Cross-border Investors 2016

Congratulations, DNV Capital Founding Partner Mr. Lin won the “2016 TOP20 of the best global early cross-border investors(China)”, DNVC investment project Venus won the “2016 TOP50 of most potential growth enterprise in China”.